Fredrick Chite Asirwa, CEO and Principal Investigator at the International Cancer Institute (ICI) and Adjunct Professor of Medicine at Kabarak University, shared on LinkedIn:
“In the pursuit of excellence in cancer education, treatment, and care, we proudly collaborated to establish a successful Master of Science in Oncology Pharmacy programme, a partnership between the International Cancer Institute and Kabarak University․
My sincere appreciation goes to the Vice Chancellor of Kabarak University, Prof. Henry Kiptiony Kiplangat (PhD, MBS, OGW), the Dean of the School of Pharmacy, Dr. Titus Suge, Dean of the School of Medicine and Health Sciences, Prof. Pamela Kimeto Tinge’i, the university staff, ICI staff and the entire Kabarak University community for their commitment, collaboration, and support in making this important milestone possible.
Prof. Henry Kiptiony Kiplangat, Dr. Titus Suge and Prof. Pamela Kimeto.
As we look forward to graduating our first cohort next month, I feel truly honoured and privileged to be part of this incredible team of dedicated professionals working together to advance the quality of cancer care through education and specialised training.
This is more than an academic programme; it is an investment in the future of oncology care and the patients and communities we serve.
Let’s Keep Building Quality!
Together, we can make a difference!”
Other articles about International Cancer Institute and Kabarak University on OncoDaily.
